247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Valiant Laboratories Limited IPO (Valiant Laboratories IPO) Details

Valiant Laboratories Limited is an Pharmaceutical based company, located in Mumbai, Valiant Laboratories Limited IPO size was 152.46 Cr. and was issued at 140.00 per share. The share of Valiant Laboratories Limited were listed at 169.05 per share and are currently trading at 99.26 per share.

Type :
Sub Sector : Manufacturing Of APIs And Bulk Drugs With A Prime Focus On Paracetamol
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
338.77 Cr.

PAT :
29.00 Cr.

Pricing Report

Issue Price :
140.00

Listing Price :
169.05

Current Market Price :
99.26

Issue Price vs CMP :
40.74 (29.10%)

listing Price vs CMP :
69.79 (41.28%)

Performance Report (CAGR* wise)

CAGR : -22.93
-ve 0 6 9 12+
Below Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Valiant Laboratories

Company Information
Valiant Laboratories Limited , an Active Pharmaceutical Ingredient (API) and bulk drug manufacturing company specializing in the production of Paracetamol, a widely used analgesic recommended as a first-line therapy for pain conditions by the World Health Organization (WHO). Bulk drugs or APIs serve as raw materials for manufacturing finished dosage forms. Paracetamol (scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2) is utilized for treating headaches, muscle aches, arthritis, backaches, toothaches, colds, and fevers. They produce Paracetamol in various grades, such as IP, BP, EP, and USP, tailored to the pharmacopeia requirements of their customers. Initially approved by the U.S. Food and Drug Administration (US FDA) in 1951, Paracetamol is available in multiple forms, including syrups, regular tablets, effervescent tablets, injections, suppositories, and combinations in over-the-counter (OTC)
Show More
Object of Issue
  • Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility
  • Investment in VASPL for funding its working capital requirements
  • General corporate purposes

Valiant Laboratories MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Oct, 2023
IPO Size :
152.46 Cr.
Market Cap :
608.30 Cr.   
IPO Subscription :
29.76 X     
PE Multiple :
0.00
IPO Registrar:
Link Intime India Private Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in Mumbai

Abans Holdings Limited

  financial service arm of the well-diversified Abans group

  Mumbai



Advanced Enzyme Technologies Limited

  research and development manufacturing and marketing of healthcare products

  Mumbai


Peer Companies Of This Sector

FAQs

Valiant Laboratories operates in Pharmaceutical and Manufacturing Of APIs And Bulk Drugs With A Prime Focus On Paracetamol. The Issue is listed on MainBoard in Oct, 2023. Valiant Laboratories IPO size was 152.46 Cr. with Issue price of 140.00 .

Merchant Banker(s) of Valiant Laboratories IPO: Unistone Capital Private Limited

Valiant Laboratories IPO subscription was 29.76 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Valiant Laboratories IPO listed at a listing price of 169.05 against the offer price of 140.00.

The current market price of Valiant Laboratories is 99.26.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency